|

Olutasidenib + TMZ Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Rigel Pharmaceuticals1

Indications

  • IDH1 R132L1
  • IDH1 R132G1
  • IDH1 R132S1
  • IDH1 R132H1
  • IDH1 R132C1

Aurora, Colorado1 trial

Study of Olutasidenib and Temozolomide in HGG

Children's Hospital Colorado

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.